See the DrugPatentWatch profile for Oxaliplatin
What is the brand name for oxaliplatin?
The pharmaceutical brand name for oxaliplatin is Eloxatin [1].
Who makes Eloxatin?
Eloxatin is manufactured by Sanofi-Aventis [2].
How does oxaliplatin work?
Oxaliplatin is a platinum-based chemotherapy drug used in the treatment of colorectal cancer [3]. It works by interfering with DNA synthesis and function, which leads to the death of cancer cells [4].
What is oxaliplatin used for?
Oxaliplatin is primarily used in combination with other chemotherapy drugs, such as fluorouracil and leucovorin, to treat stage III (advanced) colon cancer [3]. It is also used for metastatic colorectal cancer [4].
When does the patent for Eloxatin expire?
Information regarding the specific patent expiry dates for Eloxatin is publicly available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents [1]. These patents are crucial for understanding when generic versions of the drug may become available.
Can generic versions of oxaliplatin be sold?
The availability of generic versions of oxaliplatin depends on patent expiry and any regulatory approvals for those generics [1]. Once patents expire, other companies can seek approval to market their own versions of the drug.
What are the risks or side effects of oxaliplatin?
Common side effects of oxaliplatin include peripheral neuropathy (nerve damage causing numbness, tingling, or pain in the hands and feet), fatigue, nausea, vomiting, diarrhea, and low blood cell counts [4]. A significant concern with oxaliplatin is the potential for cumulative neurotoxicity, meaning the nerve damage can worsen with continued treatment [4].